Coagulation Testing Market: By Product (Clinical laboratory, Automated testing, Semi-automated testing)By Test Type (Automated testing, Semi-automated testing, D-Dimer Testing, Prothrombin Time Testing, Platelet Function Tests, Activated Clotting Time Testing, Anti-Factor Xa Tests, Others), By Technology (Optical Technology, Electrochemical Technology, Mechanical Technology), By Disease Indication (Asthma, Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Arterial Hypertension, Others), By End User (Hospitals and Clinics, Diagnostic Laboratories, Home Care Settings, and Others), and Geography

 

North-America Got Significant Share

Coagulation Testing Market

Geographically, global coagulation testing market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America coagulation testing market is growing owing to increase in the blood related diseases. According to the Centers for Disease Control and Prevention, hemophilia A affects 1 in 5,000 males. Almost 400 babies are born with hemophilia A every year. With the studies conducted in 1994, about 17,000 people were suffering from hemophilia at that time and currently it’s estimated that there are 20,000 people who would suffer from hemophilia basing on the birth and death rate since 1994. Following the North America are the regions of Europe and Asia Pacific. The Asia Pacific region is expected show the growth in the forecasted period owing to its higher awareness among the patient pool and developing healthcare infrastructure.